IGF1 and Alzheimer disease: Importantly, the low IGF-1 levels present in the brain of patients with MCI can be elevated with the practice of RE, helping to increase synaptic plasticity, neuronal survival, and cognitive performance, consequently improving AD pathophysiology (Tsai et al., 2018; Ribariè, 2022).